image
Benitec Biopharma Inc. BNTC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.68
2.69 %
$ 212 M
Market Cap
-1.94
P/E
INCOME STATEMENT
216 K REVENUE
188.00%
Growth Rates
1Year 188.00%
3Years 54.12%
5Years -54.69%
7Years -9.96%
10Years -14.36%
-22.5 M OPERATING INCOME
-17.87%
Growth Rates
1Year -17.87%
3Years -18.27%
5Years -65.00%
7Years -5.06%
10Years -4.56%
-21.8 M NET INCOME
-11.19%
Growth Rates
1Year -11.19%
3Years -16.15%
5Years -56.33%
7Years -25.76%
10Years -7.22%
EFFICIENCY
Earnings Waterfall Benitec Biopharma Inc.
image
Revenue 216 K
Cost Of Revenue 108 K
Gross Profit 108 K
Operating Expenses 22.4 M
Operating Income -22.5 M
Other Expenses -739 K
Net Income -21.8 M

Income Statement

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013
REVENUE
Revenue 0.2 75 K 73 K 59 K 97 K 11.3 0.5 0.5 0.3 0.8 1.0 0.5
GROSS PROFIT
Cost Of Revenue 0.1 0.4 9 K 0.1 0.3 0.4 0.3 0.2 0.1 30.7 K 37.7 K 0.2
Gross Profit 0.1 (0.3) 64 K 64 K (0.2) 10.9 0.1 0.2 0.2 0.8 1.0 0.4
OPERATING INCOME
Operating Expenses 22.4 19.2 17.9 13.5 8.6 9.0 8.7 4.4 16.2 8.8 11.3 7.1
Selling, General and Administrative Expenses 7.0 6.4 6.6 6.5 5.6 6.7 6.4 7.0 9.0 6.2 7.7 4.4
Research and Development Expenses 15.6 12.8 11.3 7.0 3.0 2.2 5.1 5.3 9.9 4.8 5.9 3.4
Operating Income (22.5) (19.1) (17.9) (13.6) (8.3) 2.0 (8.6) (15.9) (25.0) (13.3) (14.4) (8.2)
PRE-TAX INCOME
Interest Income Expense 0.9 33 K 32 K 6 K 0 0 0 0 0 0 0 0
Total Other Income 0.1 (0.5) (0.4) (0.3) 7 K 0.6 0.2 11.6 6.5 4.5 3.6 1.3
Pre-Tax Income (22.4) (19.6) (18.2) (13.9) (8.3) 2.9 (8.6) (4.4) (18.5) (8.8) (10.8) (6.8)
NET INCOME
Tax Provision (0.6) 3 K 0.4 (0.1) 27 K (0.9) 1.47 K 0.2 (9.0) 0.8 (4.0) (0.4)
Net Income (21.8) (19.6) (18.6) (13.8) (8.3) 2.9 (8.6) (4.4) (18.5) (8.8) (10.8) (6.4)
EPS 5.36 14.1 38.6 54.5 138 56.9 207 127 663 390 611 1.45 K